COM:VIRACTA
Viracta Therapeutics, Inc.
- Stock
Last Close
0.18
08/11 21:00
Market Cap
19.05M
Beta: -
Volume Today
745.30K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 515.50K - | 2.06M 300.58% | 2.81M 36.32% | 2.16M 23.20% | 1.78M 17.48% | 1.54M 13.40% | 1.09M 29.32% | 1.17M 7.51% | 2.23M 89.86% | 2.72M 22.05% | 2.49M 8.45% | |
average receivables | ||||||||||||
book value per share | -7.10 - | 13.79 294.17% | 22.54 63.43% | 13.40 40.53% | 8.79 34.43% | 1.12 87.23% | 3.16 181.70% | -1.25 139.51% | 2.96 337.11% | 1.62 45.40% | 0.00 99.97% | |
capex per share | -0.05 - | -0.01 - | -0.00 - | -0.13 8,874.00% | -0.00 99.11% | -0.00 99.70% | ||||||
capex to depreciation | -1.66 - | -2.89 - | -1.72 - | -23.89 1,289.83% | -0.21 99.10% | 0.09 141.23% | ||||||
capex to operating cash flow | 0.00 - | 0.00 - | 0.00 - | 0.23 6,483.84% | 0.00 99.44% | 0.00 172.57% | ||||||
capex to revenue | -0.01 - | -0.04 - | -0.46 - | |||||||||
cash per share | 45.12 - | 42.94 4.84% | 38.20 11.05% | 27.15 28.93% | 12.95 52.29% | 3.85 70.28% | 3.34 13.16% | 1.27 61.92% | 3.25 155.27% | 2.41 25.86% | 0.00 99.94% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.45 - | 0.21 53.01% | 0.17 20.33% | 0.33 100.32% | 0.21 37.16% | 0.48 130.03% | 0.15 68.08% | 0.13 16.98% | 0.05 60.54% | 0.26 419.29% | 0.45 72.02% | |
debt to equity | -2.92 - | 0.67 122.99% | 0.29 57.36% | 0.69 140.08% | 0.33 51.30% | 1.85 453.92% | 0.21 88.75% | -0.13 164.20% | 0.06 143.41% | 0.41 609.22% | 1.40 238.87% | |
dividend yield | ||||||||||||
earnings yield | -0.04 - | -0.08 92.78% | -0.16 96.24% | -0.20 22.12% | -0.12 41.79% | -0.53 356.00% | -0.23 56.67% | -0.07 67.59% | -1.75 2,247.84% | -0.90 48.32% | -0.00 99.74% | |
enterprise value | 871.90M - | 524.42M 39.85% | 211.26M 59.72% | 205.65M 2.66% | 297.64M 44.73% | 46.15M 84.50% | 97.47M 111.20% | 217.31M 122.96% | 18.25M 91.60% | 43.56M 138.67% | 22.03B 50,475.72% | |
enterprise value over ebitda | -27.54 - | -12.71 53.84% | -5.92 53.46% | -5.67 4.21% | -8.74 54.24% | -1.81 79.26% | -4.26 134.88% | -11.58 171.87% | 0.29 102.51% | -0.86 395.71% | -434.56 50,371.96% | |
ev to operating cash flow | -23.30 - | -12.14 47.87% | -5.45 55.09% | -5.56 2.00% | -8.24 48.01% | -1.89 77.04% | -4.39 132.33% | -13.54 208.11% | -0.97 92.85% | -1.23 26.89% | -552.22 44,852.96% | |
ev to sales | 109.59 - | 91.46 16.55% | 69.02 24.54% | 81.09 17.50% | 444.90 448.64% | 194.72 56.23% | 47.02 75.85% | 1.81K 3,751.66% | ||||
free cash flow per share | -42.97 - | -43.19 0.50% | -31.86 26.22% | -23.56 26.06% | -14.75 37.38% | -6.86 53.51% | -2.55 62.88% | -0.44 82.90% | -0.72 66.48% | -0.94 29.59% | -0.00 99.89% | |
free cash flow yield | -0.04 - | -0.08 86.81% | -0.17 109.04% | -0.19 10.30% | -0.11 38.57% | -0.47 308.35% | -0.21 54.13% | -0.06 70.77% | -0.20 218.36% | -0.64 223.98% | -0.00 99.72% | |
graham net net | -8.52 - | 12.53 247.07% | 22.06 76.17% | 12.99 41.13% | 7.73 40.46% | 0.66 91.41% | 2.23 235.48% | -1.28 157.48% | 2.80 318.79% | 1.49 47.01% | 0.00 99.97% | |
graham number | 82.97 - | 117.73 41.91% | 125.26 6.39% | 87.40 30.23% | 54.52 37.62% | 14.04 74.25% | 13.95 0.61% | 3.82 72.63% | 20.60 439.55% | 6.92 66.40% | 0.00 99.95% | |
income quality | 1.08 - | 1.00 7.16% | 1.06 5.17% | 0.97 7.95% | 1.02 4.85% | 0.92 10.04% | 0.95 3.71% | 0.84 11.22% | 0.16 80.54% | 0.72 338.76% | 0.78 8.41% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -10.86 - | -24.02 121.12% | -38.06 58.47% | -21.09 44.58% | -24.40 15.67% | -22.06 9.58% | -44.39 101.19% | -87.11 96.23% | 127.30 246.14% | -87.68 168.88% | 13.69 115.61% | |
interest debt per share | 24.07 - | 10.97 54.44% | 7.22 34.18% | 10.30 42.69% | 3.51 65.94% | 2.40 31.50% | 0.72 70.14% | 0.17 75.91% | 0.19 8.36% | 0.68 263.55% | 0.00 99.92% | |
inventory turnover | ||||||||||||
invested capital | -2.92 - | 0.67 122.99% | 0.29 57.36% | 0.69 140.08% | 0.33 51.30% | 1.85 453.92% | 0.21 88.75% | -0.13 164.20% | 0.06 143.41% | 0.41 609.22% | 1.40 238.87% | |
market cap | 868.98M - | 537.35M 38.16% | 230.31M 57.14% | 199.27M 13.48% | 317.41M 59.29% | 52.45M 83.48% | 103.94M 98.19% | 258.22M 148.42% | 116.33M 54.95% | 55.17M 52.57% | 22.02B 39,802.15% | |
net current asset value | -6.22M - | 13.76M 321.33% | 27.38M 98.98% | 21.02M 23.22% | 20.14M 4.18% | 3.87M 80.79% | 26.63M 588.16% | -47.31M 277.68% | 91.09M 292.56% | 58.86M 35.39% | 16.59M 71.81% | |
net debt to ebitda | -0.09 - | 0.31 439.58% | 0.53 70.24% | -0.18 132.95% | 0.58 430.34% | 0.25 57.37% | 0.28 14.37% | 2.18 669.95% | -1.56 171.79% | 0.23 114.68% | -0.26 213.72% | |
net income per share | -43.08 - | -44.68 3.71% | -30.94 30.74% | -25.33 18.13% | -15.03 40.66% | -7.80 48.08% | -2.74 64.93% | -0.52 81.04% | -6.37 1,127.74% | -1.32 79.33% | -0.00 99.90% | |
operating cash flow per share | -42.97 - | -43.14 0.38% | -31.86 26.14% | -23.56 26.06% | -14.74 37.43% | -6.86 53.48% | -2.55 62.88% | -0.43 82.96% | -0.59 36.30% | -0.94 58.62% | -0.00 99.89% | |
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 3.63 - | 4.82 32.86% | 7.74 60.48% | 9.02 16.53% | 32.20 256.86% | 61.67 91.53% | 7.43 87.94% | 112.22 1,409.49% | ||||
return on tangible assets | -0.93 - | -1.01 9.18% | -0.80 20.82% | -0.92 14.87% | -1.07 16.77% | -1.81 68.82% | -0.64 64.67% | -0.40 37.92% | -1.87 370.66% | -0.52 72.28% | -0.90 73.69% | |
revenue per share | 9.14 - | 5.73 37.30% | 2.52 56.04% | 1.62 35.81% | 0.27 83.12% | 0.07 75.59% | 0.24 257.21% | 0.00 98.64% | ||||
roe | 6.07 - | -3.24 153.41% | -1.37 57.62% | -1.89 37.67% | -1.71 9.51% | -6.95 306.54% | -0.87 87.55% | 0.42 148.00% | -2.15 617.79% | -0.81 62.14% | -2.79 242.15% | |
roic | -2.90 - | -1.86 35.72% | -1.04 44.12% | -1.07 2.85% | -1.23 15.08% | -2.33 89.40% | -0.68 70.68% | 0.49 171.16% | 1.10 126.09% | -0.59 153.75% | -1.15 94.10% | |
sales general and administrative to revenue | 1.36 - | 4.03 195.89% | 6.10 51.26% | 6.35 4.23% | 20.25 218.69% | 47.81 136.11% | 4.80 89.96% | 44.57 828.60% | ||||
shareholders equity per share | -7.10 - | 13.79 294.17% | 22.54 63.43% | 13.40 40.53% | 8.79 34.43% | 1.12 87.23% | 3.16 181.70% | -1.25 139.51% | 2.96 337.11% | 1.62 45.40% | 0.00 99.97% | |
stock based compensation to revenue | 0.49 - | 1.08 122.11% | 2.07 91.12% | 1.89 8.86% | 4.53 139.98% | 11.13 145.42% | 0.84 92.42% | 2.90 243.72% | ||||
tangible asset value | -6.18M - | 13.80M 323.19% | 27.39M 98.47% | 21.02M 23.25% | 21.54M 2.47% | 3.99M 81.47% | 27.54M 589.78% | -46.20M 267.74% | 94.37M 304.27% | 61.10M 35.25% | 18.32M 70.02% | |
tangible book value per share | -7.10 - | 13.79 294.17% | 22.54 63.43% | 13.40 40.53% | 8.79 34.43% | 1.12 87.23% | 3.16 181.70% | -1.25 139.51% | 2.96 337.11% | 1.62 45.40% | 0.00 99.97% | |
working capital | 6.52M - | 16.32M 150.35% | 27.99M 71.47% | 32.29M 15.37% | 20.25M 37.28% | 3.88M 80.86% | 26.91M 593.99% | 40.91M 52.07% | 96.19M 135.09% | 83.74M 12.95% | 16.59M 80.19% |
All numbers in (except ratios and percentages)